Reuters logo
CORRECTED-BRIEF-Asit Biotech Receives Positive Feedback From FDA On Development Plan Of Gp-Asit+ In US
December 6, 2017 / 6:07 AM / in 9 days

CORRECTED-BRIEF-Asit Biotech Receives Positive Feedback From FDA On Development Plan Of Gp-Asit+ In US

(Fixes headline and adds 2-4 bullet points.)

Dec 6 (Reuters) - Asit Biotech Sa:

* ASIT BIOTECH SIGNIFICANTLY MOVES FORWARD IN THE PREPARATION OF THE CLINICAL DEVELOPMENT PLAN OF GP-ASIT+™ IN THE US

* ‍RECEIVED POSITIVE FEEDBACK FROM FDA ON PREPARATION OF CLINICAL DEVELOPMENT PLAN FOR GP-ASIT+™ IN US

* ‍FEEDBACK FROM FDA INCLUDES A FEW COMMENTS AND REQUEST FOR SOME CLARIFICATION ON MASTER FILE

* ‍ONCE ASIT BIOTECH HAS ANSWERED FINAL QUESTIONS AND UPDATED MASTER FILE IT WILL REQUEST PRE-IND MEETING​​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below